Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timoptic for Venous Leg Ulcers
NCT00368602Phase 2Terminated
- Sponsor
- University of California, Davis
- Start
- Jun 2005
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in venous leg ulcer (VLU) comparing Timoptic with Placebo (2 arms). Primary endpoint: Complete Ulcer Healing at 12 weeks. Started Jun 2005; status: terminated.
02
Drugs
timolol
03
Conditions
venous leg ulcer (VLU)
Beyond the preview
Go deeper on NCT00368602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00368602.